Eyewire News: The Podcast
Eyewire News: The Podcast keeps listeners updated with the latest information in the ophthalmic field, featuring breaking news from press releases, medical journals, vision publications, and other news sources.
Episodes
January 7, 2026 • 11 mins
Shareholders vote on Alcon’s blockbuster acquisition proposal for Staar Surgical; the FDA responds to Outlook’s latest BLA submission for wet AMD drug Lytenava; and the FDA approves an interchangeable biosimilar to Lucentis.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played
December 31, 2025 • 8 mins
Highlights from the last 6 months of 2025 include advancements of emerging technologies in glaucoma, the first pharmacologic treatment for myopia in Europe, the expansion of labels for anti-VEGF treatments, and the release of the DEWS III report exploring the diagnosis and management of dry eye disease.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played
December 24, 2025 • 9 mins
There were several advancements made during the first 6 months of 2025, including the first FDA approval for neurodegenerative disease MacTel; the approval of a first-of-its-kind drug for dry eye disease; advancements in premium IOLs; the approval of an excimer laser platform, and the launch of a new presbyopia drop.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played
December 17, 2025 • 8 mins
Aldeyra provides an update on the timing of its dry eye disease treatment candidate reproxalap; Ocular Therapeutix pursues an accelerated NDA pathway for wet AMD therapy Axpaxli; and companies with late-stage drug candidates announce FDA submission plans.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played
December 10, 2025 • 5 mins
Companies with plans to commercialize glaucoma technologies in the US reach clinical milestones; Haag-Streit announces the global launch of a new Indirect ROP Laser Module; and EyeYon Medical gets approval to initiate a US clinical study of its EndoArt corneal implant.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played
December 3, 2025 • 5 mins
Eylea HD gains FDA approval for a new indication and dosing schedule; Lucentis biosimilar Byooviz receives a key approval in Europe; and Belite Bio announces topline results from its global phase 3 trial evaluating its drug candidate for Stargardt disease.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played
November 26, 2025 • 13 mins
Several new technologies are emerging that aim to transform the way glaucoma is treated and managed. Many of these technologies are now available to patients outside of the United States, with the goal of expanding availability to the US and beyond.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played
November 18, 2025 • 6 mins
Bausch + Lomb outlines a strategic path to innovation and growth at its Investor Day; Apellis reports new 5-year data examining Syfovre and GA progression; and two global organizations for restoring sight merge.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played
November 12, 2025 • 5 mins
Sydnexis receives another regulatory approval for its childhood myopia eye drop; Eli Lilly makes two major investments in ophthalmology; and Nanoscope reports new long-term data for its intravitreal optogenetic therapy for RP.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played
November 5, 2025 • 15 mins
Leaders of several ophthalmic companies provide updates on their pipeline and new products in this special edition of Eyewire News the Podcast.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played
October 29, 2025 • 16 mins
Leaders of several ophthalmic companies provide updates on their pipeline and new products in this special edition of Eyewire News the Podcast.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played
October 22, 2025 • 21 mins
EyewireTV reports on new products and breaking news live from thee American Academy of Ophthalmology meeting in Orlando.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played
October 15, 2025 • 7 mins
Uday Devgan, MD, shares his experience performing the world’s first robotic cataract surgery; Konan Medical receives CE Mark for its objectiveFIELD Analyzer perimetry device; and Biotech Healthcare launches a new full visual range EDOF IOL.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played
October 8, 2025 • 6 mins
A first-of-its-kind presbyopia eye drop is now commercially available; Lumibird introduces ICL Guru Integration on its ultrasound platform; and the makers of gene therapy candidates for retinal diseases provide clinical updates.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played
October 1, 2025 • 17 mins
Industry executives discuss future innovations and breakthroughs that are poised to reshape the future of ophthalmic care.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played
September 24, 2025 • 18 mins
Industry executives discuss future innovations and breakthroughs that are poised to reshape the future of ophthalmic care.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played
September 17, 2025 • 16 mins
EyewireTV reports on new products and breaking news live from the ESCRS Congress in Copenhagen.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played
September 10, 2025 • 15 mins
A proposal by the Trump Administration calls for cuts to the National Institutes of Health and consolidation of the federal government’s 27 institutes into just eight. This includes folding the National Eye Institute into a new broader institute on neuroscience and brain research. Ophthalmic leaders discuss what the vision care advocacy community is doing to combat proposed cuts to the National Eye Institute.
Learn more about your...
Mark as Played
September 3, 2025 • 7 mins
Several companies with treatment candidates for retinal diseases provide clinical updates; Nicox releases new phase 3 data for its investigational glaucoma eye drop; the first patient is implanted with Ocumetics’ novel accommodating lens; and ASCRS provides details for its second annual Business of Refractive Cataract Surgery Summit.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played
August 27, 2025 • 4 mins
Ciliatech obtains CE certification for the Intercil Uveal Spacer surgical implant; Zeiss receives CE mark for a new device that uses AI to automate OCT assessment; and the FDA extends the target action dates for two Eylea HD submissions.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played
Popular Podcasts
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.
The official podcast of comedian Joe Rogan.
Two Guys (Bowen Yang and Matt Rogers). Five Rings (you know, from the Olympics logo). One essential podcast for the 2026 Milan-Cortina Winter Olympics. Bowen Yang (SNL, Wicked) and Matt Rogers (Palm Royale, No Good Deed) of Las Culturistas are back for a second season of Two Guys, Five Rings, a collaboration with NBC Sports and iHeartRadio. In this 15-episode event, Bowen and Matt discuss the top storylines, obsess over Italian culture, and find out what really goes on in the Olympic Village.
The Clay Travis and Buck Sexton Show. Clay Travis and Buck Sexton tackle the biggest stories in news, politics and current events with intelligence and humor. From the border crisis, to the madness of cancel culture and far-left missteps, Clay and Buck guide listeners through the latest headlines and hot topics with fun and entertaining conversations and opinions.
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com